2021
DOI: 10.1155/2021/6653790
|View full text |Cite
|
Sign up to set email alerts
|

H2O2‐Driven Anticancer Activity of Mn Porphyrins and the Underlying Molecular Pathways

Abstract: Mn(III) ortho-N-alkyl- and N-alkoxyalkyl porphyrins (MnPs) were initially developed as superoxide dismutase (SOD) mimics. These compounds were later shown to react with numerous reactive species (such as ONOO-, H2O2, H2S, CO3•-, ascorbate, and GSH). Moreover, the ability of MnPs to oxidatively modify activities of numerous proteins has emerged as their major mechanism of action both in normal and in cancer cells. Among those proteins are transcription factors (NF-κB and Nrf2), mitogen-activated protein kinases… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
38
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 43 publications
(62 citation statements)
references
References 153 publications
1
38
0
Order By: Relevance
“…Redox imbalance in the tumor is particularly relevant during tumor growth and neovascularization. Cationic Mn(III) meso -tetrakis( N -n-hexylpyridinium-2-yl)porphyrin (MnTnHex-2-PyP 5+ ;MnHex), a potent lipophilic mimic of the family of porphyrin-based superoxide dismutases (SOD), has been shown to reduce oxidative damage by directly or indirectly reducing the levels of reactive species, thereby restoring the cellular physiological redox state [ 1 , 2 , 3 , 4 , 5 ]. Its analog, MnTnBuOE-2-PyP 5+ [Mn(III) meso -tetrakis( N -n-butoxyethylpyridinium-2-yl)porphyrin, BMX-001], is in four clinical trials as radioprotectant of normal tissue and tumor radio- and chemosensitizer [ 6 , 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…Redox imbalance in the tumor is particularly relevant during tumor growth and neovascularization. Cationic Mn(III) meso -tetrakis( N -n-hexylpyridinium-2-yl)porphyrin (MnTnHex-2-PyP 5+ ;MnHex), a potent lipophilic mimic of the family of porphyrin-based superoxide dismutases (SOD), has been shown to reduce oxidative damage by directly or indirectly reducing the levels of reactive species, thereby restoring the cellular physiological redox state [ 1 , 2 , 3 , 4 , 5 ]. Its analog, MnTnBuOE-2-PyP 5+ [Mn(III) meso -tetrakis( N -n-butoxyethylpyridinium-2-yl)porphyrin, BMX-001], is in four clinical trials as radioprotectant of normal tissue and tumor radio- and chemosensitizer [ 6 , 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…Our studies taught us that ortho Mn porphyrins are able to promote the HA degradation in the presence of Cu(II) [or Fe(III)] and ascorbate. Such knowledge increases our insight into their anticancer therapeutic potential [22][23][24][25]. Scheme 1.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, development of manganese porphyrin compounds that alter the redox biology of mitochondria has generated interest as possible dual tumor radiosensitizers and normal tissue radioprotectors. 93 Preclinical findings of preserved tumor control and neuroprotection with enhanced cognitive function following irradiation in mice spawned clinical trials in several cancer types, including brain metastases 87 (NCT03608020). The role of GSK-3beta inhibition as a general neuroprotection strategy that prevents radiation necrosis 88 is also exciting, and some clinical trial data exist for tideglusib in Alzheimer’s disease patients.…”
Section: Future Directionsmentioning
confidence: 99%